Prevention of coronary heart disease

BMJ 2004; 328 doi: 10.1136/bmj.328.7436.405-a (Published 12 February 2004)
Cite this as: BMJ 2004;328:405.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Incremental cost effectiveness raises issues

  1. William C D'Avanzo, retired (davanzo@prodigy.net)
  1. 21B Kenneth Stuart Place, Mohegan Lake, NY 10547

    EDITOR—Marshall seemed not to include the cost to the health system of treatment after a myocardial infarction occurs.1 You could go further and estimate the cost to society of prematurely losing productive members.

    Say, for example, one myocardial infarction was prevented with treatment A and two with treatment B in a group of 100. If A costs $1 a year and …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL